Covid19 Clinical Trial
Official title:
Impact of Spectacles on Compliance to Mask-wearing Directives in Greece
Verified date | September 2020 |
Source | Democritus University of Thrace |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Primary objective of this study is to identify the compliance of Greek people in mask-wearing directive and explore potential associations with refractive errors, spectacles and contact lenses use.
Status | Completed |
Enrollment | 1214 |
Est. completion date | August 14, 2020 |
Est. primary completion date | July 24, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Age >18 years old - Adequate literacy of Greek language - Permanent residence in Greece Exclusion Criteria: - Poor knowledge of Greek language |
Country | Name | City | State |
---|---|---|---|
Greece | University Hospital of Alexandroupolis | Alexandroupolis | Evros |
Lead Sponsor | Collaborator |
---|---|
Democritus University of Thrace |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Demographic characteristics | Gender Age Use of spectacles (a. no use, b. for distance, c. for near, d. for distance and near) Use of contact lenses (a. no use, b. rarely, c. frequently, d. almost always) Belonging to a vulnerable group (1. No, 2. Yes, 3. I don't know) Binocular Distance Best Spectacle-Corrected Visual Acuity (if it is known) (1. I don't know, 2. <1/10, 3. 1-3/10, 4. 4-6/10, 5. 7-8/10, 6. 9-10/10) |
last 3 months | |
Primary | Compliance to mask-wearing directives | Compliance to mask-wearing directives Yes, always Yes, almost always Sometimes No, almost never No, never |
last 3 months | |
Primary | Questionnaire subscale: Near vision | Difficulty in near vision activities (reading a printed document in the workplace or in daily life, reading a document on computer in the workplace or in daily life, reading a message on mobile phone) when using a face mask No difficulty Little difficulty Some difficulty Great difficulty I have stopped this activity because of my vision and the use of face mask I need to remove my face mask |
last 3 months | |
Primary | Questionnaire subscale: Distance vision | Difficulty in distance vision activities (recognizing people on the opposite sidewalk, reading road and shop signs, crossing roads) when using a face mask No difficulty Little difficulty Some difficulty Great difficulty I have stopped this activity because of my vision and the use of face mask I need to remove my face mask |
last 3 months | |
Primary | Questionnaire subscale: Ocular discomfort | Ocular discomfort (tearing sensation, stinging sensation, general discomfort) when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months | |
Primary | Questionnaire subscale: Driving | Difficulty in driving (during day or night, in known or unknown places) when using a face mask No difficulty Little difficulty Some difficulty Great difficulty I have stopped this activity because of my vision and the use of face mask I need to remove my face mask |
last 3 months | |
Primary | Questionnaire subscale: Limitation | Limitation during physical activity, entertainment, social relationships, professional and learning development when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months | |
Primary | Questionnaire subscale: Collaboration | Difficulty in collaboration with colleagues in the workplace when using a face mask No difficulty Little difficulty Some difficulty Great difficulty I have stopped this activity because of my vision and the use of face mask I need to remove my face mask |
last 3 months | |
Primary | Questionnaire subscale: Need for help | Need for help during shopping (supermarket, grocery store, bakery) or in public services (bank etc) when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months | |
Primary | Questionnaire subscale: Emotional impact | Emotional charge when using a face mask 5-point Likert scale (1 = I absolutely agree / 5 = I absolutely disagree) |
last 3 months | |
Secondary | Assessment of the relationship between the compliance to mask-wearing directives and the use of spectacles | Chi-squared test will be performed to assess if the compliance to mask-wearing directives is related to the use of spectacles | immediately after the completion of data collection | |
Secondary | Assessment of the relationship between the compliance to mask-wearing directives and the other demographic characteristics | Chi-squared test will be performed to assess if the compliance to mask-wearing directives is related to the other demographic characteristics | immediately after the completion of data collection | |
Secondary | Assessment of the relationship between the compliance to mask-wearing directives and the questionnaire items | Chi-squared test will be performed to assess if the compliance to mask-wearing directives is related to the 20 questionnaire items and the corresponding subscales (outcome measures 3-10) | immediately after the completion of data collection | |
Secondary | Assessment of the relationship between demographic characteristics and the 20 questionnaire items | Chi-squared test will be performed to assess if demographic characteristics are related to the 20 items of the questionnaire and to the corresponding subscales (outcome measures 3-10) | immediately after the completion of data collection |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |